Task X8: Efficacy Testing of Filovirus Vaccines in Non-Human Primates

传染病疫苗和其他生物制品评估和测试服务(ETS)合同提供从早期可行性研究到I/II阶段材料生产的各种产品开发服务，包括分析开发、免疫原性和有效性测试、临床和非临床样本测试以及安全和毒性测试。这些服务将促进开发和引入新的疫苗和生物制品，以应对生物恐怖主义、抗药性病原体以及新出现和重新出现的传染病的潜在病原体。

The Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of product development services from early feasibility studies through manufacture of Phase I/II material, including assay development; immunogenicity and efficacy testing; clinical and nonclinical sample testing; and safety and toxicity testing. These services will facilitate the development and introduction of new vaccines and biologics against potential agents of bioterrorism, drug-resistant pathogens, and emerging and re-emerging infectious diseases.